Clinical Trials Browser

Small Cell Lung Carcinoma × iadademstat × Endocrine × Clear all

NCT05420636 2025-07-30

Iadademstat in Combination With Paclitaxel in Relapsed/Refractory SCLC and Extrapulmonary High Grade NET

Phase 2 Terminated

EndocrineThoracic

Carcinoma, Neuroendocrine, Small Cell Lung Carcinoma